Feedback / Questions
ofirnoflast (HT-6184) - Halia Therap
https://www.prnewswire.com/news-releases/halia-therapeutics-announces-positive-phase-2a-data-for-ofirnoflast-in-lower-risk-mds-at-ash-2025-302635415.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next